CMND
Clearmind Medicine Inc

3,444
Mkt Cap
$4.32M
Volume
6.1M
52W High
$2.18
52W Low
$0.18
PE Ratio
-0.24
CMND Fundamentals
Price
$0.206
Prev Close
$0.2025
Open
$0.195
50D MA
$0.8713
Beta
0.35
Avg. Volume
737,848.22
EPS (Annual)
-$1.70
P/B
1.02
Loading...
Loading...
News
all
press releases
Penny Stocks To Add to Your Watchlist - November 13th
Leap Therapeutics, Nuvve, Bitfarms, Safe & Green, TNL Mediagene, Strive, and Clearmind Medicine are the seven Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Clearmind Medicine (CMND) Stock Soars Thursday: What's Going On?
Clearmind Medicine Inc (NASDAQ:CMND) shares are trading higher on Thursday. Here's a look at what you need to know.read more...
Benzinga·7d ago
News Placeholder
Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy. read more...
Benzinga·1y ago
News Placeholder
Could Psychedelics End Binge Drinking? A Breakthrough Patent Says Yes
Clearmind Medicine secures a U.S. patent for its MEAI-based binge behavior treatment, marking a significant advancement in addressing Alcohol Use Disorder. read more...
Benzinga·1y ago
News Placeholder
Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher
Clearmind Medicine shares are trading higher Friday after the company announced advancement in its proprietary MEAI-based binge behavior regulator program through the granting of patent approval in...
Benzinga·1y ago
News Placeholder
What's Going On With Clearmind Medicine Stock Tuesday?
Clearmind said its alcohol substitute was granted patents in the U.S., India and Europe. The company also highlighted that the no/low alcohol category is forecasted to grow at a volume CAGR of more...
Benzinga·1y ago
News Placeholder
Why Clearmind Medicine Stock Is Moving Higher
Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research Development. read more...
Benzinga·2y ago
News Placeholder
Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Declines By 59.8%
Clearmind Medicine Inc. (NASDAQ:CMND Get Free Report) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 92,700 shares, a decline of...
Ticker Report·2y ago
News Placeholder
Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression
Vancouver, Canada, March 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) ( Clearmind or the company ), a biotech company focused on discovery and development of...
Globe Newswire·2y ago
News Placeholder
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
Globe Newswire·2y ago

Latest CMND News

View

Advertisement|Remove ads.

Advertisement|Remove ads.